Pharmacy startups are getting into the business of prescribing medications — and it shows how a new business model is taking over in healthcare

Prescription savings website GoodRx just acquired telemedicine startup HeyDoctor and plans to use the service to connect those scanning its website with doctors who can…

Read More Pharmacy startups are getting into the business of prescribing medications — and it shows how a new business model is taking over in healthcare

A major data-manipulation scandal has rocked Novartis. Here's everything we learned from a new 59-page letter the Swiss drug giant sent to its regulators.

A data-manipulation scandal has rocked Swiss drug giant Novartis and its new rare-disease treatment Zolgensma. A clearer picture is now emerging with a new59-page letter…

Read More A major data-manipulation scandal has rocked Novartis. Here's everything we learned from a new 59-page letter the Swiss drug giant sent to its regulators.

The CEO of cannabis-tech startup Headset told us why having a concise mission statement is crucial to successfully pitching investors

The CEO ofHeadset, a data-analytics provider for the cannabis industry, revealed his key advice for making a successful pitch to potential investors. Cy Scott walked…

Read More The CEO of cannabis-tech startup Headset told us why having a concise mission statement is crucial to successfully pitching investors

Pioneering genetic-testing company Myriad's biggest new product is facing pushback from US regulators that could 'significantly limit' the test's appeal. The stock is down 40%.

This story requires our BI Prime membership. To read the full article, simply click here to claim your deal and get access to all exclusive…

Read More Pioneering genetic-testing company Myriad's biggest new product is facing pushback from US regulators that could 'significantly limit' the test's appeal. The stock is down 40%.

A startup led by a former Google exec and a pioneering scientist just raised $2.8 million to tackle a little-understood condition that affects 10 million people

A new startup led by a veteran of Google’s Verily and the Swiss drug giant Roche is tackling women’s health issues like urinary tract infections.…

Read More A startup led by a former Google exec and a pioneering scientist just raised $2.8 million to tackle a little-understood condition that affects 10 million people

Flare Capital just raised $255 million, and the buzzy VC firm's cofounder told us he wants to invest in companies trying to reinvent the way we get healthcare in the US

Flare Capital Partners raised $255 million in its latest fund and cofounder Michael Greeley told us what he wants to invest in next. Greeley said…

Read More Flare Capital just raised $255 million, and the buzzy VC firm's cofounder told us he wants to invest in companies trying to reinvent the way we get healthcare in the US

Using apps to treat diseases could be the future of healthcare. The first chief digital officer at pharma giant Sanofi told us his strategy for navigating the promises and pitfalls.

French drugmakerSanofi recently appointed Chief Medical OfficerAmeet Nathwani as its chief digital officer. The pharma industry is increasingly hiring chief digital officers as it seeks…

Read More Using apps to treat diseases could be the future of healthcare. The first chief digital officer at pharma giant Sanofi told us his strategy for navigating the promises and pitfalls.

A longtime healthcare VC just posted her 13 rules for entrepreneurs and investors, and they’re required reading for any startup that wants to get into the industry

Healthcare investor and author Lisa Suennenreleased a list of “13 rules for healthcare entrepreneurs and investors.” The list was created in response to Mark Cuban’s…

Read More A longtime healthcare VC just posted her 13 rules for entrepreneurs and investors, and they’re required reading for any startup that wants to get into the industry

Clover Health set out to upend healthcare for aging Americans. 5 years and $925 million in funding later, it's proving more challenging than expected.

If Vivek Garipalli, CEO and founder ofClover Health, could do it over again, he’s not sure he’d get into the health insurance business. “If I…

Read More Clover Health set out to upend healthcare for aging Americans. 5 years and $925 million in funding later, it's proving more challenging than expected.

We spoke with a key Merck executive about the strategy for its top cancer drug, a $7 billion powerhouse that could soon bring in more than $20 billion

Merck’s cancer drug Keytruda uses the body’s natural disease-fighting immune response to combat cancer. It has become apowerhouse for the company, bringing in $7 billion…

Read More We spoke with a key Merck executive about the strategy for its top cancer drug, a $7 billion powerhouse that could soon bring in more than $20 billion

Marketers say that Amazon's advertising business is difficult to navigate. Here's why the company thinks the 'chaotic' structure actually makes sense.

Amazon’s advertising business is growing, particularly in video advertising and measurement. But its ad business is spread across several teams, which can make it hard…

Read More Marketers say that Amazon's advertising business is difficult to navigate. Here's why the company thinks the 'chaotic' structure actually makes sense.

We spoke to the president of AstraZeneca about the pharma giant’s plans to get back to growth after losing billions in sales to generic competition

UK-based pharma giant AstraZeneca has lost $12 billion in revenue in the past few years. That’s been in large part because of generic competition that’s…

Read More We spoke to the president of AstraZeneca about the pharma giant’s plans to get back to growth after losing billions in sales to generic competition

The Atlantic thinks it’s found a winning formula for events by leaning on its weighty journalism, and the business is booming

The Atlantic Festival this week will be the publication’s largest stand-alone event with more than 15 underwriters and 2,500 attendees. AtlanticLive puts on more than…

Read More The Atlantic thinks it’s found a winning formula for events by leaning on its weighty journalism, and the business is booming